Richard D. Leavitt
- Molecular Biology top 10%
- Hematology top 1%
- Immunology top 10%
- Genetics top 5%
- Oncology top 10%
- Co-authors
- Ronald L. FelstedN R BachurFarhad RavandiJean‐Pierre J. IssaVirginia M. KlimekMaher AlbitarJohn F. DiPersioRichard E. Helmer
- Topics
- Acute Myeloid Leukemia Research (7 papers)Toxin Mechanisms and Immunotoxins (4 papers)Acute Lymphoblastic Leukemia research (4 papers)
- Cited by
- HematologyGeneticsImmunology
- Partner nations
- United StatesGermanyIndia
In The Last Decade
Richard D. Leavitt
25 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Molecular Biology 1.1k
- Hematology 954
- Immunology 329
- Genetics 286
- Oncology 279
Countries citing papers authored by Richard D. Leavitt
This map shows the geographic impact of Richard D. Leavitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Leavitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Leavitt more than expected).
Fields of papers citing papers by Richard D. Leavitt
This network shows the impact of papers produced by Richard D. Leavitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Leavitt. The network helps show where Richard D. Leavitt may publish in the future.
Co-authorship network of co-authors of Richard D. Leavitt
This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Leavitt. A scholar is included among the top collaborators of Richard D. Leavitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Leavitt. Richard D. Leavitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 27 | |
| 3 | Decitabine improves patient outcomes in myelodysplastic syndromesbreakdown → | 1139 |
| 4 | 28 | |
| 5 | 30 | |
| 6 | 14 | |
| 7 | The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia. | 63 |
| 8 | 24 | |
| 9 | 39 | |
| 10 | 110 | |
| 11 | 7 | |
| 12 | Effects of recombinant interferon-alpha on immune function in cancer patients. | 11 |
| 13 | 13 | |
| 14 | 12 | |
| 15 | 56 | |
| 16 | 189 | |
| 17 | 4 | |
| 18 | 3 | |
| 19 | 106 | |
| 20 | 6 |
About Richard D. Leavitt
Richard D. Leavitt is a scholar working on Otorhinolaryngology, Hematology and Immunology, having authored 25 papers that have together received 2.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). The work is most often cited by research in Hematology (954 citations), Genetics (286 citations) and Immunology (329 citations). Richard D. Leavitt has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Ronald L. Felsted, N R Bachur, Farhad Ravandi, Jean‐Pierre J. Issa, Virginia M. Klimek, Maher Albitar, John F. DiPersio, Richard E. Helmer, Stephen D. Nimer and Azra Raza. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.